Financial News
Headline News about Takeda Pharmaceutical Ltd ADR
![](https://cdn.benzinga.com/files/images/story/2022/11/23/takeda.png?width=1200&height=800&fit=crop)
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
November 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/22/screenshot_2022-11-22_at_7.24.03_pm.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/710337/a-scientist-uses-a-pipette-to-work-with-medical-samples.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/1600x900.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/709201/people-reviewing-financials-on-a-screen.jpg)
![](https://g.foolcdn.com/editorial/images/707488/gettyimages-1014182354.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/27/takeda.png?width=1200&height=800&fit=crop)
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
October 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19488.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/05/aapharma_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9009.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/21/aapharma_9.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/11/dividends-1600.jpg)
![](https://www.investors.com/wp-content/uploads/2022/10/A1MAIN_GeneEdit_102122.jpg)
![](https://g.foolcdn.com/editorial/images/704944/businessman-showing-chart-to-co-worker.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/21/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/01/stock-gene-03-adobe.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/stockstobuy1600_11.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/30/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/30/bz-pharma_0.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/30/aapharma_8.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/26/elon_musk_3018710552.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/26/aapharma.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/22/bz-pharma_6.jpg?width=1200&height=800&fit=crop)
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/10/Stock-DrugSpill-02-adobe.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_14273.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/07/27/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/26/covid_vaccine-photo_by_hakan_german_from_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_12639.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_21107.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/18/aapharma_19.png?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.